A new survey from the COPD Action Alliance shows that people living with chronic obstructive pulmonary disease (COPD)…
Articles by Margarida Maia, PhD
A urine test developed in a dipstick format by Global Access Diagnostics helped not only distinguish between stable and…
Oral supplementation with nicotinamide riboside, a form of vitamin B3, helped reduce markers of lung inflammation in older adults with…
The U.S. Food and Drug Administration has cleared the start of clinical trial testing of KT-621, Kymera Therapeutics’ oral…
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with…
Adding GSK’s mepolizumab to standard inhaled treatment reduces the frequency of moderate to severe exacerbations in chronic obstructive pulmonary…
A higher genetic risk for chronic obstructive pulmonary disease (COPD) is associated with reduced lung function starting in childhood,…
Enrollment is now complete in a clinical trial testing RejuvenAir, CSA Medical’s minimally invasive device, in adults with chronic…
Young adults who smoke or have smoked may halve their risk of developing emphysema — a form of chronic…
A research team at The Lundquist Institute has been awarded a four-year grant to develop a wearable biosensor that can…